Global Market for Non-Invasive Prenatal Testing is Anticipated to grow at a Significant Pace i.e., USD 19.21 Billion during the Forecast Period 2021-2027

Published Date: Dec, 2021

The global Non-Invasive Prenatal Testing Market is anticipated to grow at 16.35% CAGR during the forecast period. Factors attributing to the growth of the Non-Invasive Prenatal Testing Market include the rising prominence of SSIs, rising number of surgical procedures, technological development of innovating new products, significant increase in the occurrence of complications from HAIs, and rising geriatric population. Nevertheless, the growing initiatives by government and rising number of collaborations by key industry players will create opportunities for growth of the Non-Invasive Prenatal Testing Market.

3M is on the mission to protect patients from preventable surgical site infections (SSIs) as they believe that up to 5% of patients undergoing surgery may have negative consequences of an SSI, as patients might have an increased length of stay in hospital that can impact the quality of life. So they are committed to using their best practices and evidence-based solutions to reduce the risk of SSIs in the facility

The COVID-19 outbreak has had a negative impact on Non-Invasive Prenatal Testing Market owing to decrease in funding of R&D activities associated with surgical site infection control agents and decrease in number of elective surgeries will adversely affect the market.

Browse 60 market data Tables and 35 Figures spread through 200 Pages and in-depth TOC on " Non-Invasive Prenatal Testing Market by Product (Instruments and Consumables), by Method (Cell- Free DNA in Maternal Plasma Tests, Ultrasound Detection, Fetal Cell in Maternal Blood Tests, and Biochemical Screening Tests), by Application (Microdeletion Syndrome, Trisomy and Others), and by End User (Hospitals and Diagnostic Laboratories), and Region - Global Forecast to 2027"

By product, antibiotic prophylaxis contributes to the largest share in the Non-Invasive Prenatal Testing Market in 2020.

Based on product, the Non-Invasive Prenatal Testing Market is segmented into wound care dressings, antibiotic prophylaxis products, clippers, surgical drapes, antiseptics and disinfectants, surgical staff clothing, patient-warming products, wound irrigation products, wound care supplementary products and others. The antibiotic prophylaxis dominate the market owing to the increased cost of antibiotics, acceptance of antibiotics as most established preventive method for surgical site infections and patient friendly dosage forms like tablets, capsules, etc.

Global Non-Invasive Prenatal Testing Market Segmentation Analysis

Segment

Categorization

Leading Category

Product

Instruments and Consumables

Antibiotic Prophylaxis (Largest)

Antiseptics and Disinfectants (Fastest)

Method

Cell- Free DNA in Maternal Plasma Tests, Ultrasound Detection, Fetal Cell in Maternal Blood Tests, and Biochemical Screening Tests

Intraoperative (Largest)

 

Application

Microdeletion Syndrome, Trisomy and Others

 

End User

Hospitals and Diagnostic Laboratories

Ambulatory Surgery Centers (Fastest)

Region

North America, Europe, Asia-Pacific, and Rest of the World

North America (Largest)

Asia-Pacific (Fastest)

Discover More About This Report, Download A Free Sample Copy of Global Non-Invasive Prenatal Testing Market

“Asia-Pacific is anticipated to be the fastest growing region in the Non-Invasive Prenatal Testing Market during 2021-2027.”

Asia-Pacific is expected to be the fastest-growing region in the Non-Invasive Prenatal Testing Market owing to increasing patient pool, increased awareness by government organizations, abd rising prominence of surgical site infections.

Some of the major players in the Non-Invasive Prenatal Testing Market include 3M Company, Medtronic plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Covalon Technologies Ltd., Stryker Corporation, Becton, Dickinson and Company, Prescient Surgical Inc., Surgical Site Infection Prevention LLC, and STERIS plc.

Scope of the Report

Report Metric

Details

Market Size Available for the Years in the Study

2015–2027

Historical Period

2015–2020

Base Year

2020

Forecast Period

2021–2027

Segments Covered in the Study

Product, Method, Application, End User, and Region

Geographies Covered in the Study

North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia), Asia-Pacific (China, Japan, India, South Korea), and Rest of the World (Brazil, Saudi Arabia, South Africa, U.A.E.)

Companies Covered in the Study

3M Company, Medtronic plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Covalon Technologies Ltd., Stryker Corporation, Becton, Dickinson and Company, Prescient Surgical Inc., Surgical Site Infection Prevention LLC, and STERIS plc

Global Non-Invasive Prenatal Testing Market Coverage

Product Insight and Forecast 2015-2027

  • Instruments
  • Consumables

Method Insight and Forecast 2015-2027

  • Cell- Free DNA in Maternal Plasma Tests
  • Ultrasound Detection
  • Fetal Cell in Maternal Blood Tests
  • Biochemical Screening Tests

Application Insight and Forecast 2015-2027

  • Microdeletion Syndrome
  • Trisomy
  • Others

End User Insight and Forecast 2015-2027

  • Hospitals
  • Diagnostic Laboratories

Geographical Segmentation

Non-Invasive Prenatal Testing Market by Region

North America

  • By Product
  • By Method
  • By Application
  • By End User
  • By Country – U.S., Canada, and Mexico

Europe

  • By Product
  • By Method
  • By Application
  • By End User
  • By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

  • By Product
  • By Method
  • By Application
  • By End User
  • By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

  • By Product
  • By Method
  • By Application
  • By End User
  • By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries

 

 

Our Industry
Global Market for Non-Invasive Prenatal Testing is Anticipated to grow at a Significant Pace i.e., USD 19.21 Billion during the Forecast Period 2021-2027